Skip to main content
Caplight Logo









Neurofit

Neurofit

Private
TorontoHealthcare & Life Scienceshttps://neurofit.ca

Last Round

Accelerator

Sep 12, 2022

Est. Valuation

$3M

Total Funding Raised

$120,000

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Neurofit operates in Healthcare & Life Sciences and is based in Toronto. Its latest recorded funding round was an Accelerator round in September 2022.

Neurofit is a healthcare technology company that provides a virtual reality platform for cognitive rehabilitation.

Sector

Healthcare & Life Sciences

Verticals

Vertical SaaS, Patient Engagement, Mental Health

Business Model

B2B

Customer Profile

Usage-Based SaaS, Freemium, Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Neurofit Comparables

Compare Neurofit with similar companies based on industry and business-model similarity.

Neurofit comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cognishine
86%
HeadApp
86%
Constant Therapy Health
84%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Neurofit Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorSep 12, 2022
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Neurofit Investors

Notable investors and investment history

Neurofit investors
InvestorRounds
TechstarsAccelerator
UNT Health Science CenterAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 190% MoM.

  • Jun 21, 2026

    Monthly visitors grew 15388% MoM, from 8 to 1.2K.

Book a demo to see all signals

For institutional investors. Book with your work email.

Neurofit Filings

Explore SEC and related filing metadata, where available.

Neurofit filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Neurofit's valuation, stock price, and market status.

Is Neurofit a public or private company?

Neurofit is a private company.

What is the current stock price of Neurofit?

Neurofit is a private company, so its shares have no public market price. Caplight tracks Neurofit's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Neurofit worth (valuation)?

Neurofit's valuation is estimated at $3.0M based on funding round data.

Can I buy Neurofit stock?

Neurofit shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Neurofit's last funding round?

Neurofit's most recent funding round was Accelerator on September 12, 2022.

Who are the main investors in Neurofit?

Key investors in Neurofit include Techstars, UNT Health Science Center.

Will Neurofit IPO soon?

No public IPO plans have been announced for Neurofit.

How can I track Neurofit secondary market activity?

Caplight tracks bids, offers, and trades in Neurofit's shares on secondary markets.

Firmographic Details

HeadquartersToronto
Employee Range4
Year Founded2019
Last FundingSep 12, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?